Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia

Molecular Human Reproduction

Volumn 12, Issue 6, 2006, Pages 389-399

  Gellhaus, Alexandra ^a   Schmidt, Markus ^a   Dunk, Caroline ^b   Lye, Stephen J ^b   Kimmig, Rainer ^a   Winterhager, Elke ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Angiogenesis; CCN; CYR61; NOV; Placenta; Pre eclampsia

Indexed keywords

CD34 ANTIGEN; CYSTEINE RICH PROTEIN 61; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE LOCATION; GESTATION PERIOD; GIANT CELL; HELLP SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOCYTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TROPHOBLAST; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; FEMALE; HELLP SYNDROME; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROSCOPY, FLUORESCENCE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33745589760     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gal044     Document Type: Article

References (51)

1. Anteby EY, Greenfield C, Natanson-Yaron S, Goldman-Wohl D, Hamani Y, Khudyak V, Ariel I and Yagel S (2004) Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9. Mol Hum Reprod 10,229-235.
2. Anteby EY, Ayesh S, Shochina M, Hamani Y, Schneider T, Al-Shareef W, Hochberg A and Ariel I (2005) Growth factor receptor-protein bound 2 (GRB2) upregulation in the placenta in preeclampsia implies a possible role for ras signalling. Eur J Obstet Gynecol Reprod Biol 118,174-181.
3. Babic AM, Kireeva ML, Kolesnikova TV and Lau LF (1998) CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95,6355-6360.
4. Baxter JK and Weinstein L (2004) HELLP syndrome: The state of the art. Obstet Gynecol Surv 59,838-845.
5. Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, Serra M, Parenza M, Martinez V, Picci P and Scotlandi K (2005) In Ewing's sarcoma CCN3 (NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24,4349-4361.
6. Benirschke K and Kaufmann P, eds. (2000) Pathology of the Human Placenta, 4th edn. Springer-Verlag, New York.
7. Bleau AM, Planque N and Perbal B (2005) CCN proteins and cancer: Two to tango. Front Biosci 10,998-1009.
8. Castellucci M, Scheper M, Scheffen I, Celona A and Kaufmann P (1990) The development of the human placental villous tree. Anat Embryol (Berl) 181,117-128.
9. Chakraborty C, Gleeson LM, McKinnon T and Lala PK (2002) Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol 80,116-124.
10. Chen N, Leu SJ, Todorovic V, Lam SC and Lau LF (2004) Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for proangiogenic activities in vascular endothelial cells. J Biol Chem 279,44166-44176.
11. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield PN and Perbal B (1998) novH: Differential expression in developing kidney and Wilm's tumors. Am J Pathol 152,1563-1575.
12. Coukos G, Makrigiannakis A, Amin K, Albelda SM and Coutifaris C (1998) Platelet-endothelial cell adhesion molecule-1 is expressed by a subpopulation of human trophoblasts: A possible mechanism for trophoblast-endothelial interaction during haemochorial placentation. Mol Hum Reprod 4,357-367.
13. Cross JC (2000) Genetic insights into trophoblast differentiation and placental morphogenesis. Semin Cell Dev Biol 11,105-113.
14. Dunk C and Ahmed A (2001) Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. Histol Histopathol 16,359-375.
15. Dye JF, Jablenska R, Donnelly JL, Lawrence L, Leach L, Clark P and Firth JA (2001) Phenotype of the endothelium in the human term placenta. Placenta 22,32-43.
16. Egbor M, Ansari T, Morris N, Green CJ and Sibbons PD (2005) Pre-eclampsia and fetal growth restriction: How morphometrically different is the placenta? Placenta [Epub ahead of print].
17. Ellis PD, Chen Q, Barker PJ, Metcalfe JC and Kemp PR (2000) NOV gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. Arterioscler Thromb Vasc Biol 20,1912-1919.
18. Ellis PD, Metcalfe JC, Hyvonen M and Kemp PR (2003) Adhesion of endothelial cells to NOV is mediated by the integrins alphavbeta 3 and alpha5beta1. J Vasc Res 40,234-243.
19. Fisher SJ (2004) The placental problem: Linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2,53.
20. Gellhaus A, Dong X, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ et al. (2004) Connexin43 interacts with NOV: A possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 279,36931-36942.
21. Huppertz B (2006) Molecular markers for human placental investigation. Methods Mol Med 121,337-350.
22. Kaufmann P, Mayhew TM and Charnock-Jones DS (2004) Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 25,114-126.
23. Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS and Lau LF (1997) Cyr61 and Fisp12 are both ECM-associated signaling molecules: Activities, metabolism, and localization during development. Exp Cell Res 233,63-77.
24. Kolesnikova TV and Lau LF (1998) Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells. Oncogene 16,747-754.
25. Lam C, Lim KH and Karumanchi SA (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46,1077-1085.
26. Latinkic BV, Mo FE, Greenspan JA, Copeland NG, Gilbert DJ, Jenkins NA, Ross SR and Lau LF (2001) Promoter function of the angiogenic inducer Cyr61gene in transgenic mice: Tissue specificity, inducibility during wound healing, and role of the serum response element. Endocrinology 142,2549-2557.
27. Leu SJ, Lam SC and Lau LF (2002) Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem 277,46248-46255.
28. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, Yeung CY and Lau LF (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278,24200-24208.
29. Lyall F, Greer IA, Boswell F, Young A, Macara LM and Jeffers MD (1995) Expression of cell adhesion molecules in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth retardation. Placenta 16,579-587.
30. Mayhew TM, Charnock-Jones DS and Kaufmann P (2004a) Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 25,127-139.
31. Mayhew TM, Wijesekara J, Baker PN and Ong SS (2004b) Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. Placenta 25,829-833.
32. Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC and Lau LF (2002) CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 22,8709-8720.
33. Myatt L (2002) Role of placenta in preeclampsia. Endocrine 19,103-111.
34. O'Brien TP and Lau LF (1992) Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development. Cell Growth Differ 3,645-654.
35. Perbal B (2001) NOV (nephroblastoma overexpressed) and the CCN family of genes: Structural and functional issues. Mol Pathol. 54,57-79.
36. Perbal B (2004) CCN proteins: Multifunctional signalling regulators. Lancet 363,62-64.
37. Pridjian G and Puschett JB (2002) Preeclampsia. Part 1: Clinical and pathophysiologic considerations. Obstet Gynecol Surv 57,598-618.
38. Rachal AW and Brigstock DR (2005) Structural and functional properties of CCN proteins. Vitam Horm 70,69-103.
39. Redman CW and Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308,1592-1594.
40. Roberts JM and Redman CW (1993) Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 341,1447-1451.
41. Sane DC, Anton L and Brosnihan KB (2004) Angiogenic growth factors and hypertension. Angiogenesis 7,193-201.
42. Schutze N, Kunzi-Rapp K, Wagemanns R, Noth U, Jatzke S and Jakob F (2005) Expression, purification, and functional testing of recombinant CYR61/CCN1. Protein Expr Purif 42,219-225.
43. Sgambati E, Marini M, Zappoli Thyrion GD, Parretti E, Mello G, Orlando C, Simi L, Tricarico C, Gheri G and Brizzi E (2004) VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG 111,564-570.
44. Sibai BM (2004) Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103,981-991.
45. Sibai B, Dekker G and Kupferminc M (2005) Pre-eclampsia. Lancet 365,785-799.
46. Winterhager E, Stutenkemper R, Traub O, Beyer E and Willecke K (1991) Expression of different connexin genes in rat uterus during decidualization and at term. Eur J Cell Biol 55,133-142.
47. Zhong XY, Gebhardt S, Hillermann R, Tofa KC, Holzgreve W and Hahn S (2005) Circulatory nucleosome levels are significantly increased in early and late-onset preeclampsia. Prenat Diagn 25,700-703.
48. Zhou Y, Damsky CH, Chiu K, Roberts JM and Fisher SJ (1993) Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 91,950-960.
49. Zhou Y, Damsky CH and Fisher SJ (1997a) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99,2152-2164.
50. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M and Damsky CH (1997b) Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99,2139-2151.
51. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C and Fisher SJ (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160,1405-1423.